Long-term outcome of omalizumab-assisted desensitisation to cow’s milk and eggs in patients refractory to conventional oral immunotherapy: real-life study | Zendy

Roser Ayats | Zendy; Silvia Riera-Rubió | Zendy; Laura Valdesoiro Navarrete | Zendy; Miguel García González | Zendy; Helena Larramona-Carrera | Zendy; Oscar Asensio-De la Cruz | Zendy; Montserrat Bosque-García | Zendy

Open Access

Long-term outcome of omalizumab-assisted desensitisation to cow’s milk and eggs in patients refractory to conventional oral immunotherapy: real-life study

Author(s) -

Roser Ayats,

Silvia Riera-Rubió,

Laura Valdesoiro Navarrete,

Miguel García González,

Helena Larramona-Carrera,

Oscar Asensio-De la Cruz,

Montserrat Bosque-García

Publication year - 2022

Publication title -

allergologia et immunopathologia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.483

H-Index - 37

eISSN - 1578-1267

pISSN - 0301-0546

DOI - 10.15586/aei.v50i3.537

Subject(s) - medicine , omalizumab , refractory (planetary science) , immunotherapy , life saving , immunology , immunoglobulin e , antibody , immune system , physics , astrobiology , medical emergency

Oral immunotherapy (OIT) is a promising approach to cow's milk and egg allergies, but reactions are frequent and some patients cannot be desensitized.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research